CERVARIX is indicated in females from 10 to 45 years of age for the prevention of persistent infection, premalignant cervical lesions and cervical cancer caused by human papillomavirus types 16 and 18. lmmunogenicity studies have been conducted in females aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to other populations (See Precautions and Clinical Trials).
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Turbid liquid after shaking. White deposit and colourless supernatant after sedimentation
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
CERVARIX is indicated in females from 10 to 45 years of age for the prevention of persistent infection, premalignant cervical lesions and cervical cancer caused by human papillomavirus types 16 and 18. lmmunogenicity studies have been conducted in females aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to other populations (See Precautions and Clinical Trials).
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Turbid liquid after shaking. White deposit and colourless supernatant after sedimentation
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
CERVARIX is indicated in females from 10 to 45 years of age for the prevention of persistent infection, premalignant cervical lesions and cervical cancer caused by human papillomavirus types 16 and 18. lmmunogenicity studies have been conducted in females aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to other populations (See Precautions and Clinical Trials).
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Turbid liquid after shaking. White deposit and colourless supernatant after sedimentation
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
CERVARIX is indicated in females from 10 to 45 years of age for the prevention of
persistent infection, premalignant cervical lesions and cervical cancer caused by human
papillomavirus types 16 and 18. Immunogenicity studies have been conducted in females
aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to
other populations. (See Precautions and Clinical Trials).,CERVARIX is indicated in females from 10 to 45 years for the prevention of Cervical Cancer by protecting against incident and persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) and cervical intraepithelial neoplasia (CIN), CIN 1 and pre-cancerous lesions (CIN 2 and CIN 3) caused by human papillomavirus types 16 and 18. Immunogenicity studies have been conducted in females aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to other populations.
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Tubid liquid after shaking. White deposit and colourless supernatant after sedimentation
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
CERVARIX is indicated in females from 10 to 45 years of age for the prevention of
persistent infection, premalignant cervical lesions and cervical cancer caused by human
papillomavirus types 16 and 18. Immunogenicity studies have been conducted in females
aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to
other populations. (See Precautions and Clinical Trials).,CERVARIX is indicated in females from 10 to 45 years for the prevention of Cervical Cancer by protecting against incident and persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) and cervical intraepithelial neoplasia (CIN), CIN 1 and pre-cancerous lesions (CIN 2 and CIN 3) caused by human papillomavirus types 16 and 18. Immunogenicity studies have been conducted in females aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to other populations.
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Tubid liquid after shaking. White deposit and colourless supernatant after sedimentation
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
CERVARIX is indicated in females from 10 to 45 years of age for the prevention of
persistent infection, premalignant cervical lesions and cervical cancer caused by human
papillomavirus types 16 and 18. Immunogenicity studies have been conducted in females
aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to
other populations. (See Precautions and Clinical Trials).,CERVARIX is indicated in females from 10 to 45 years for the prevention of Cervical Cancer by protecting against incident and persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) and cervical intraepithelial neoplasia (CIN), CIN 1 and pre-cancerous lesions (CIN 2 and CIN 3) caused by human papillomavirus types 16 and 18. Immunogenicity studies have been conducted in females aged 10 to 14 years and 26 to 45 years to link efficacy in females aged 15 to 25 years to other populations.
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Tubid liquid after shaking. White deposit and colourless supernatant after sedimentation
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
Support for this browser is being discontinued
Support for this browser is being discontinued for this site
Internet Explorer 11 and lower
We currently support Microsoft Edge, Chrome, Firefox and Safari. For more information, please visit the links below:
